OXA (beta)-lactamases in Acinetobacter: the story so far.
about
Carbapenemases: the versatile beta-lactamasesAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideStructure of the extended-spectrum class C β-lactamase ADC-1 fromAcinetobacter baumanniiInsights on the Horizontal Gene Transfer of Carbapenemase Determinants in the Opportunistic Pathogen Acinetobacter baumanniiCarbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast AsiaClinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem useRisk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control studyInhibition of OXA-1 beta-lactamase by penems.Multidrug resistant acinetobacter.Penicillin sulfone inhibitors of class D beta-lactamasesEmergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in TaiwanOutbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in BelgiumDrug treatment for multidrug-resistant Acinetobacter baumannii infections.Acinetobacter baumannii: emergence of a successful pathogenCurrent strategies for the prevention and management of central line-associated bloodstream infections.Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China.Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogensGlobal challenge of multidrug-resistant Acinetobacter baumanniiAn OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitalsClinical and economic impact of common multidrug-resistant gram-negative bacilliTreatment options for multidrug-resistant bacteria.Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern BrazilAcinetobacter baumannii: an emerging multidrug-resistant threat.OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives.Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species.Bacterial contamination in intensive care unit at Al-Imam Al-Hussein Hospital in Thi-qar province in Iraq.Molecular Detection of Class-D OXA Carbapenemase Genes in Biofilm and Non-Biofilm Forming Clinical Isolates of Acinetobacter baumannii.In vitro activity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D β-lactamase-producing Acinetobacter baumannii.Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic ManagementMolecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysisCharacterization of Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Hospitalized Patients in Palestine.The role of the genetic elements bla oxa and IS Aba 1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting.Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.
P2860
Q24685034-9258A497-59BE-4927-B3D8-1B8DFD1AD7C5Q27024893-F650A60F-EAAE-4768-881A-6E570BA13F05Q27682002-4A3E8105-8DA2-4AD0-BD4A-509F6EFE825BQ28078376-FED0F0BC-933E-41F0-8E43-C854805F0E08Q28078775-68F6959B-18F7-4CAC-B4FA-A24367C13B52Q28299749-278A65FA-7005-4F80-96F5-FFB861948AD2Q28538923-08046701-344C-4BA5-A000-C76C9C6951BCQ33344365-1240CC4F-21AF-4851-ABB9-DE31F1906E64Q33711902-C506B005-BC9E-4C02-ABC1-5CBB6D16CFE7Q33768836-D33901F4-245E-4F2C-922E-B35E401D3CF8Q34290153-EB66573A-69E5-40F7-AE7A-9ED939502367Q34564018-387BB0DB-880B-4152-A612-5BC402F977DDQ34601684-AB89D035-D13A-4D62-AA04-81648EF779F1Q34795807-77C60B80-4D7C-4B40-82C3-4FFA5B641208Q35026591-BC478781-4A79-4903-A285-C6D326F86D2DQ35270933-7B5F25DD-5820-450D-9A17-E6CE1FB955CEQ35561864-88D118AA-9DE9-4EB0-A657-724D618AB0F6Q36095081-843AA732-F6B9-4FF1-A46C-7AA8682E9F9AQ36295342-0A78ADBD-9B0E-4262-B095-647A8325EB36Q36295402-E52B9EB3-D41E-4903-8800-C53583C740B9Q36482801-E9C5CAB6-E361-4473-B8FA-8E6F4DF8F9FAQ36607401-44AAD293-1BA3-4167-A994-B15A7DAE2CBAQ36744790-6510B722-9E23-4FE2-BFAD-5714886F98C4Q37160172-40FB3B0C-A035-4E9E-B69F-906A30061FCAQ37202840-D77C69BC-CC6F-4996-9128-9996EBED5AD3Q37450717-7EEA0811-44BE-4B95-9F84-068816FB3660Q37485601-07B38019-0DBB-4AB9-AC20-83E6A64D046BQ37656243-032D4053-C763-414A-8924-E5F423E4F887Q37838117-D87905F8-0157-4DD6-95B0-EAC3A2346EB4Q38360685-F476873F-6271-4465-B4E5-C7993B4CF21CQ38471963-98E134A9-4544-4CED-9EDD-7948A05F631EQ38757741-789C28B6-0880-44D4-9590-4F45AD3075ABQ38885950-91B2892C-C8EA-44BA-8D16-FE128C9038EEQ38945089-6F87C461-304F-4DE8-A559-A3076716A111Q39279278-AFD0C318-2263-4109-B394-127072A425D6Q39900310-4023464A-AFCE-4159-93C1-3BBB3A1EE6C3Q40080697-A48F06E6-32D1-4D52-BE5F-FD33A3CDD36AQ40550690-84732BD4-E64F-4CCC-B317-22CC9798EB86Q41026343-AACE59D7-05F6-4E55-902B-351B21B94AF8Q41337352-3C9F8E98-528A-48BB-A1EB-7B7940C6824F
P2860
OXA (beta)-lactamases in Acinetobacter: the story so far.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
OXA (beta)-lactamases in Acinetobacter: the story so far.
@ast
OXA (beta)-lactamases in Acinetobacter: the story so far.
@en
type
label
OXA (beta)-lactamases in Acinetobacter: the story so far.
@ast
OXA (beta)-lactamases in Acinetobacter: the story so far.
@en
prefLabel
OXA (beta)-lactamases in Acinetobacter: the story so far.
@ast
OXA (beta)-lactamases in Acinetobacter: the story so far.
@en
P356
P1476
OXA (beta)-lactamases in Acinetobacter: the story so far.
@en
P2093
Sebastian Amyes
Susan Brown
P356
10.1093/JAC/DKI425
P407
P577
2005-12-06T00:00:00Z